Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
97.22    -0.96 (-0.98%)
Bid:
97.08
Ask:
97.12
Spread: 0.04 (0.041%)
Market Cap: £56.63b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Board Change

13 Oct 2025 09:18

RNS Number : 0983D
Lloyds Banking Group PLC
13 October 2025
 

13 October 2025

LLOYDS BANKING GROUP PLC: BOARD CHANGE

Lloyds Banking Group plc ("LBG") announces that Scott Wheway will step down as a Non-Executive Director of LBG and as Chair of Scottish Widows Group with effect from 31 October 2025. Scott, who is also a member of the LBG Board Risk Committee and Nomination and Governance Committee, is leaving to take up the position of Chair at Legal & General Group Plc where he will become a Non-Executive Director from 2 January 2026. A process will be run for the next Chair of Scottish Widows Group. Chris Moulder, the Senior Independent Director of Scottish Widows Group, will take on the role of interim Chair of Scottish Widows Group subject to regulatory approval.

Sir Robin Budenberg, LBG Chair, said: "I and the Board would like to thank Scott for the contribution he has made to LBG and for the leadership and commercial acumen he has brought to the Board and in his role as Chair of Scottish Widows Group. He leaves with our thanks and best wishes for his new role. I am grateful to Chris for taking on the role of interim Chair of Scottish Widows Group."

 

END

For further information:

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

 

 

+44 (0) 7788 352487

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKNBDFBDKOKD
Date   Source Headline
15th Mar 20235:33 pmRNSTransaction in Own Shares
14th Mar 20235:20 pmRNSTransaction in Own Shares
13th Mar 20235:29 pmRNSTransaction in Own Shares
10th Mar 20235:58 pmRNSTransaction in Own Shares
10th Mar 20234:07 pmRNSDirector/PDMR Shareholding
9th Mar 20235:43 pmRNSTransaction in Own Shares
8th Mar 20236:06 pmRNSTransaction in Own Shares
8th Mar 20232:26 pmRNSDirector/PDMR Shareholding
7th Mar 20235:39 pmRNSTransaction in Own Shares
7th Mar 20233:08 pmRNS2022 Form 20F Filed
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
6th Mar 20235:52 pmRNSTransaction in Own Shares
3rd Mar 20235:41 pmRNSTransaction in Own Shares
2nd Mar 20235:37 pmRNSTransaction in Own Shares
2nd Mar 202312:04 pmRNSPublication of Final Terms
1st Mar 20235:26 pmRNSTransaction in Own Shares
28th Feb 20235:41 pmRNSTransaction in Own Shares
28th Feb 20233:37 pmRNSTotal Voting Rights
27th Feb 20235:26 pmRNSTransaction in Own Shares
27th Feb 20232:00 pmRNSDirector/PDMR Shareholding
24th Feb 20235:46 pmRNSTransaction in Own Shares
24th Feb 20235:03 pmRNS2022 Form 20F Filed
23rd Feb 20236:07 pmRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSShare Buyback Programme Commences
22nd Feb 202311:38 amRNSPublication of Suppl.Prospcts
22nd Feb 20237:00 amRNS2022 Annual Report and Accounts
22nd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20235:00 pmRNSDirector/PDMR Shareholding
31st Jan 20234:57 pmRNSTotal Voting Rights
11th Jan 20232:36 pmRNSPublication of Final Terms
11th Jan 20232:15 pmRNSDirector/PDMR Shareholding
3rd Jan 202310:00 amRNSBlock listing Interim Review
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20224:36 pmRNSDirector/PDMR Shareholding
12th Dec 20224:09 pmRNSDirector/PDMR Shareholding
7th Dec 20222:00 pmRNSBlock Listing of Shares
1st Dec 20229:57 amRNSDirector/PDMR Shareholding
30th Nov 20223:31 pmRNSTotal Voting Rights
16th Nov 20224:30 pmRNSDirector/PDMR Shareholding
10th Nov 20223:30 pmRNSDirector/PDMR Shareholding
1st Nov 20229:43 amRNSDirector Declaration
31st Oct 20222:18 pmRNSTotal Voting Rights
27th Oct 202212:07 pmRNSPublication of Supplementary Prospectus
27th Oct 202212:01 pmRNS2022 Q3 Interim Management Statement
27th Oct 20227:00 amRNS2022 Q3 Interim Management Statement
12th Oct 20222:00 pmRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSLBG COMPLETES SHARE BUYBACK PROGRAMME
11th Oct 20225:27 pmRNSTransaction in Own Shares
11th Oct 20229:06 amRNSLBG ANNOUNCES RESULTS OF TENDER OFFER

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.